Name | Title | Contact Details |
---|
Brogan Heart Center is a Lubbock, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Zai Lab is an innovative, research-based, commercial stage biopharmaceutical company based in China and the U.S. focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Headquartered in Shanghai since our founding in 2014, our experienced team has secured partnerships with leading global biopharma companies, generating a broad and late-stage pipeline of innovative drug candidates. Based on our extensive track record of execution and delivering results, Zai Lab has earned the reputation as a trusted partner of choice for global biopharmaceutical companies seeking to not only access the Chinese market but also find a long-term strategic partner for global clinical development. Through these partnerships, Zai Lab has built the strongest late stage oncology portfolio with global first-in-class and/or best-in-class profile, among innovative Chinese biotech companies. We are further supplementing our pipeline with an in-house discovery effort aiming to produce 1-2 global INDs per year. Zai Lab is rapidly expanding into a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing innovative medicines. To that end, we have built our internal R&D center to advance our discovery pipeline, a strong clinical development and operations team, and our own manufacturing facilities in China. We have also established a highly specialized commercial team to support marketing of our innovative products in China. We believe this integrated approach will provide sustainable competitive advantages for Zai Lab. Zai Lab was successfully listed on the Nasdaq Stock Market in September 2017. Since then, Zai Lab significantly expanded with several offices across China and opened its U.S. headquarters in San Francisco in December 2018. As of December 2019, the Company has a global team of approximately 700 employees.
Miraca Life Sciences serves more than 5,500 patients each day, providing expert pathology services in the fields of dermatopathology, breast pathology, gastroenterology, hematology/oncology and urology. Additionally, Miraca has provided health IT consulting services to hundreds of practices, helping providers with programs such as MIPS, quality reporting, Meaningful Use, security risk assessments, and HIPAA compliance. The company, previously known as Caris Diagnostics, was renamed Miraca Life Sciences in February 2012. Miraca Life Sciences is a subsidiary of Miraca Holdings Inc., one of Japan`s largest clinical diagnostics and laboratory testing service providers. As a leader in anatomic pathology, Miraca Life Sciences combines the rigor of an academic medical institution with the innovative spirit of a technology company. By working for Miraca, you will have the opportunity to contribute alongside top multidisciplinary talented professionals, who are dedicated to meeting the needs of our clients and their patients. You will work in a state-of-the-art environment with cutting-edge tools, breakthrough technologies and with world-renowned thought leaders. The company offers a forward-thinking business model seeking to make a profound difference in the quality of care for patients.
InCyte Pathology is the premier provider of anatomic diagnostic services in the Northwest. Our state-of-the-art facility based in Spokane Valley, Washington, is owned and operated by pathologists dedicated to providing patients with comprehensive
Life Science Laboratories is a East Syracuse, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.